Cover Image

Comparative Effectiveness of Ampicillin/Sulbactam versus Cefazolin as Targeted Therapy for Bacteremia Caused by Beta-Lactamase-Producing Methicillin-Sensitive <i>Staphylococcus aureus</i>: A Single-Center Retrospective Study

Cefazolin (CFZ) is the first-line treatment for beta-lactamase-producing methicillin-sensitive <i>Staphylococcus aureus</i> (BP-MSSA) infection. In 2019, Japan experienced a CFZ shortage because of foreign object inclusion in a batch. Ampicillin/sulbactam (SAM) was preferred in many case...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jun Hirai (Author), Nobuhiro Asai (Author), Mao Hagihara (Author), Takaaki Kishino (Author), Hideo Kato (Author), Daisuke Sakanashi (Author), Wataru Ohashi (Author), Hiroshige Mikamo (Author)
Format:	Book
Published:	MDPI AG, 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
by: Hideo Kato, et al.
Published: (2022)

Clinical Efficacy of Fidaxomicin and Oral Metronidazole for Treating <i>Clostridioides difficile</i> Infection and the Associated Recurrence Rate: A Retrospective Cohort Study
by: Nobuaki Mori, et al.
Published: (2023)

A Systematic Review and Meta-Analysis of Efficacy and Safety of Azithromycin Versus Moxifloxacin for the Initial Treatment of <i>Mycoplasma genitalium</i> Infection
by: Hideo Kato, et al.
Published: (2022)

In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing <i>Enterobacter cloacae</i> and <i>Klebsiella pneumoniae</i> in Murine Pneumonia Model
by: Mao Hagihara, et al.
Published: (2021)

Comparison of Cefazolin/Metronidazole to Ampicillin/Sulbactam as Preoperative Antibiotics in Colorectal Surgery: A Retrospective, Single-Center Cohort Study
by: Jae Hyoung Im, et al.
Published: (2023)

Incidence of Postpartum Endomyometritis Following Single-Dose Antibiotic Prophylaxis With Either Ampicillin/Sulbactam, Cefazolin, or Cefotetan in High-Risk Cesarean Section Patients
by: N. Noyes, et al.
Published: (1998)

Days of Antibiotic Spectrum Coverage (DASC) as a Metric for Evaluating the Impact of Prospective Audit and Feedback (PAF) against Long-Term Broad-Spectrum Antibiotic Use
by: Yuichi Shibata, et al.
Published: (2024)

Tackling Intrinsic Antibiotic Resistance in <i>Serratia marcescens</i> with a Combination of Ampicillin/Sulbactam and Phage SALSA
by: Lorenz Weber, et al.
Published: (2020)

Retrospective Comparison of the Effectiveness and Safety of Ceftriaxone 1 g Twice Daily versus 2 g Once Daily for Treatment of Aspiration Pneumonia
by: Hideo Kato, et al.
Published: (2022)

Ampicillin/Sulbactam Vs. Cefoxitin for the Treatment of Pelvic Inflammatory Disease
by: Joseph G. Jemsek, et al.
Published: (1997)

Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
by: Marguerite L. Monogue, et al.
Published: (2018)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including <i>Acinetobacter baumannii</i>
by: Tetsushu Onita, et al.
Published: (2023)

A Retrospective Study to Compare the Incidence of Hyponatremia after Administration between Linezolid and Tedizolid
by: Yuichi Shibata, et al.
Published: (2023)

Efficacy of Trimethoprim-Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis
by: Hideo Kato, et al.
Published: (2022)

A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients
by: Hideo Kato, et al.
Published: (2022)

The molecular changing mechanism of Ampicillin-Sulbactam resistant Staphylococcus aureus towards Methicillin resistant Staphylococcus aureus
by: Mieke Hemiawati Satari
Published: (2005)

Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible <i>Staphylococcus aureus</i> in a Tertiary Care University Hospital
by: Atsushi Uda, et al.
Published: (2021)

The diagnostic ability of plasma Procalcitonin levels in Gram positive bacteremia
by: Y Koizumi, et al.
Published: (2020)

Efficacy of Combination Therapies for the Treatment of Multi-Drug Resistant Gram-Negative Bacterial Infections Based on Meta-Analyses
by: Takumi Umemura, et al.
Published: (2022)

Inpatient Treatment for Uncomplicated and Complicated Acute Pelvic Inflammatory Disease: Ampicillin/Sulbactam Vs. Cefoxitin
by: David L. Hemsell, et al.
Published: (1993)

The Impact of Cefepime and Ampicillin/Sulbactam on Preventing Post-Cesarean Surgical Site Infections, Randomized Controlled Trail
by: Mona A. Abdelrahman, et al.
Published: (2023)

Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against <i>Acinetobacter</i> spp.
by: Cristina Lasarte-Monterrubio, et al.
Published: (2021)

Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients
by: Hideo Kato, et al.
Published: (2021)

Comparing Treatment Outcomes of Ampicillin-Sulbactam, Other β-Lactams, and Vancomycin in Blood Culture-Negative Infective Endocarditis
by: Se Ju Lee, et al.
Published: (2021)

Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single‐center retrospective observational study
by: Tomokazu Suzuki, et al.
Published: (2021)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) Isolates
by: Fernando Pasteran, et al.
Published: (2021)

β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance
by: Shogo Yamada, et al.
Published: (2020)

<i>Acinetobacter baumannii</i> Resistance to Sulbactam/Durlobactam: A Systematic Review
by: Luigi Principe, et al.
Published: (2022)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023)

In Vitro Efficacy of Antibiotic Combinations with Carbapenems and Other Agents against Anaerobic Bacteria
by: Takumi Umemura, et al.
Published: (2022)

Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria
by: Marta Palombo, et al.
Published: (2023)

Antibacterial activity against β- lactamase producing Methicillin and Ampicillin-resistants <it>Staphylococcus aureus</it>: fractional Inhibitory Concentration Index (FICI) determination
by: Konaté Kiessoun, et al.
Published: (2012)

Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant <i>Acinetobacter baumannii</i> Infections-A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2024)

Persistent Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: Host, Pathogen, and Treatment
by: Joshua B. Parsons, et al.
Published: (2023)

Efficacy of Cefoperazone Sulbactam in Patients with <i>Acinetobacter</i> Infections: A Systematic Review of the Literature
by: Gowthami Sai Kogilathota Jagirdhar, et al.
Published: (2023)

Identification and Characterization of Genes Related to Ampicillin Antibiotic Resistance in <i>Zymomonas mobilis</i>
by: Binan Geng, et al.
Published: (2022)

LL37-Derived Fragments Improve the Antibacterial Potential of Penicillin G and Ampicillin against Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Wenxu Han, et al.
Published: (2023)

In Vivo-Acquired Resistance to Daptomycin during Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia
by: Adeline Boutet-Dubois, et al.
Published: (2023)

Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
by: Benjamin H. Gern, et al.
Published: (2018)

Effects of the cefazolin shortage on the sales, cost, and appropriate use of other antimicrobials
by: Ryuji Koizumi, et al.
Published: (2021)